What is RingConn?
RingConn is a $279 subscription-free smart ring biometric (Gen 2 / Gen 3 variants), positioned as the subscription-free anchor within the ring sub-cohort distinct from Oura purchase+membership + Whoop subscription-only commercial models. CRITICAL CAP-FLAG per Agent A Wave 2 biometric ingest: AHI (apnea-hypopnea index) marketed at 90.7%-claimed accuracy but NOT FDA-cleared; company PR explicitly states 'actively pursuing clearance' + 'not intended to diagnose.' Sharp within-cohort verified-vs-claimed counterpoint to Happy Ring's actual K240236 + K242224 FDA clearances. ITC outcome correction per Agent A: RingConn settled-licensed cleanly with Oura on '178 patent (NOT banned; Ultrahuman was blocked). Cohort positioning: subscription-free ring archetype within biometric cluster's ring sub-cohort.
$279
One-time purchase; subscription-free model
AHI 90.7% claimed
Marketing accuracy claim; NOT FDA-cleared
ITC settled-licensed
Clean Oura '178 patent license (NOT banned)
Gen 2 + Gen 3 variants
Line-level entity scope
Sleep apnea NOT cleared
FDA clearance status cap-flag
Mid-2026
Snapshot date
RingConn: subscription-free ring archetype
RingConn (Gen 2 / Gen 3) is a $279 subscription-free smart ring biometric from RingConn. Per DEPLOY's biometric cluster framework, RingConn anchors the subscription-free ring archetype within the ring sub-cohort, structurally distinct from Oura purchase+membership and Whoop subscription-only commercial models.
Subscription-free commercial model distinction
Per Agent A Wave 2 biometric ingest, RingConn operates a subscription-free commercial model: $279 unit purchase with all features unlocked at point-of-sale; no monthly or annual subscription required for AI insights + sleep tracking + cardiovascular biometric features. Per DEPLOY's framework, the subscription-free positioning matters editorially at the commercial-model verification layer:
- RingConn (subscription-free): $279 one-time purchase; all features included.
- Oura (purchase + membership): hardware purchase + $5.99/mo Oura Membership for AI insights.
- Whoop (subscription-only): hardware subsidized; $239/yr subscription required for any data access.
The subscription-free archetype matters at the ring sub-cohort positioning layer: trade-press coverage that flattens the three commercial models operates outside Agent A primary-source-anchored verification. RingConn's subscription-free positioning is the load-bearing commercial-model distinction within the ring sub-cohort.
CRITICAL CAP-FLAG: AHI 90.7%-claimed but NOT FDA-cleared
Per Agent A Wave 2 biometric ingest, RingConn's AHI (apnea-hypopnea index) is marketed at 90.7%-claimed accuracy but is NOT FDA-cleared. Company PR explicitly states 'actively pursuing clearance' and 'not intended to diagnose'. Per cap-flag-as-trust-signal, this is a critical cap-flag against trade-press coverage that frames RingConn AHI claims at FDA-cleared verification posture.
Per DEPLOY's framework, the AHI-claimed-not-cleared posture creates a sharp within-cohort verified-vs-claimed counterpoint to Happy Ring: same form factor (smart ring), similar capability claims (sleep apnea detection), and diametrically opposite verification posture:
- RingConn AHI: 90.7%-claimed, NOT FDA-cleared; "actively pursuing clearance" + "not intended to diagnose" company-stated.
- Happy Ring: dual FDA 510(k) clearances; K240236 (Oct 8 2024 remote monitoring) + K242224 (Jun 18 2025 home sleep test diagnosis support, clinician-directed).
The within-cohort verified-vs-claimed pair is the editorial throughline at the biometric cluster's FDA-clearance verification layer. Per DEPLOY's framework, the pair operates recursively on DEPLOY's own verified-vs-claimed framework: same product category + similar capability claims at opposite verification postures is the canonical framework worked example.
ITC outcome: RingConn settled-licensed (CORRECTED from "banned")
Per Agent A Wave 2 biometric ingest correction, the ITC outcome on the Oura '178 patent dispute requires precise scope. RingConn settled cleanly with Oura on the '178 patent and obtained a license. RingConn was NOT banned from the US market. Ultrahuman was the entity blocked via the ITC final determination (subsequently restored via the Ring Pro unibody redesign cleared US Customs March 24 2026).
Per DEPLOY's framework, the ITC-outcome correction matters editorially: trade-press coverage that frames RingConn at the banned-from-US-market verification posture operates outside Agent A primary-source-anchored verification. The settled-licensed RingConn vs blocked-then-restored Ultrahuman distinction is editorial signal at the IP-litigation cohort outcome layer.
Gen 2 + Gen 3 variants
Per Agent A Wave 2 biometric ingest + slug audit, the RingConn registry entity scope is modelName "RingConn (Gen 2 / Gen 3)": both generation variants covered within a single entity record at the line-level slug per DEPLOY's slug-discipline pattern. The Gen 2 + Gen 3 variants share the subscription-free commercial model + AHI-claimed-not-cleared verification posture.
Cohort positioning: subscription-free ring archetype
Per the biometric cluster framework, RingConn anchors:
- Subscription-free ring archetype: $279 one-time purchase; distinct from Oura purchase+membership + Whoop subscription-only.
- AHI-claimed-not-cleared verification posture: 90.7%-claimed accuracy; "actively pursuing clearance"; within-cohort verified-vs-claimed counterpoint to Happy Ring's actual FDA clearances.
- ITC settled-licensed: clean license with Oura on '178 patent; NOT banned; Ultrahuman was the blocked entity.
- Gen 2 + Gen 3 line-level entity scope: both variants covered within single modelName.
Contrast with cohort:
- Happy Ring: dual FDA clearances (K240236 + K242224); service-gated availability; sharp verified-vs-claimed counterpoint to RingConn AHI claims.
- Ultrahuman Ring (Air / Pro): market-access-redesigned archetype; US blocked Oct 21 2025 → restored March 24 2026 via Ring Pro unibody redesign.
- Oura Ring (purchase+membership): existing biometric cluster anchor; hardware purchase + monthly membership commercial model.
- Whoop: subscription-only band cohort exemplar; ~$478 Year 1 effective cost.
For the canonical biometric cluster context, see the biometric cluster. For the within-cohort verified-vs-claimed counterpoint, see what is Happy Ring. For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to RingConn: verified-vs-claimed at within-entity granularity (CANONICAL ITC settled-licensed verification trajectory within Oura '178 patent ITC family) + the 9-tier source-quality rubric (ITC determination primary-government-record source classification).
| Entity | Commercial model | FDA clearance posture | Cohort archetype |
|---|---|---|---|
RingConn (Gen 2 / Gen 3) | $279 subscription-free | AHI claimed-not-cleared (90.7%); actively pursuing clearance | Subscription-free ring |
Happy Ring | Service-gated (insurer-billed Happy Sleep) | Dual 510(k): K240236 + K242224 | FDA-cleared service-gated ring |
Ultrahuman Ring (Air / Pro) | Hardware + subscription-augmented (~$349) | AFib via FibriCheck third-party app (NOT native) | Market-access-redesigned ring |
Oura Ring | Hardware purchase + $5.99/mo membership | Native features + cycle tracking | Purchase+membership ring |
Whoop | Subscription-only (~$478 Year 1) | BP Insights warning letter (unresolved); class action active | Subscription-only band |
Apple Watch | Hardware purchase (no AI subscription) | ECG + AFib detection + SpO2 (disabled then restored) | Platform smartwatch with FDA features |
Frequently asked questions
- What is RingConn?
RingConn is a $279 subscription-free smart ring biometric (Gen 2 / Gen 3 variants) from RingConn. Per Agent A Wave 2 biometric ingest, RingConn anchors the subscription-free ring archetype within the biometric cluster's ring sub-cohort, distinct from Oura purchase+membership and Whoop subscription-only commercial models. CRITICAL CAP-FLAG: AHI (apnea-hypopnea index) marketed at 90.7%-claimed accuracy but NOT FDA-cleared; company PR explicit "actively pursuing clearance" + "not intended to diagnose."
- How much does RingConn cost?
$279 one-time purchase, subscription-free per Agent A Wave 2 biometric ingest. The subscription-free commercial model is structurally distinct from Oura (hardware purchase + $5.99/mo Oura Membership) and Whoop (~$478 Year 1 subscription-only). Per DEPLOY's framework, the subscription-free archetype is the load-bearing commercial-model distinction within the ring sub-cohort. The consumer surface at deploy.report/price/ringconn-gen2 documents the verified $279 + subscription-free framing.
- Is RingConn FDA-cleared for sleep apnea?
No, RingConn's AHI (apnea-hypopnea index) feature is NOT FDA-cleared per Agent A Wave 2 biometric ingest. RingConn markets AHI at 90.7%-claimed accuracy, but company PR explicitly states 'actively pursuing clearance' and 'not intended to diagnose.' Per cap-flag-as-trust-signal, this is a critical cap-flag against trade-press coverage framing RingConn AHI at FDA-cleared verification posture. Per DEPLOY's framework, the company-PR explicit qualifications are the load-bearing primary-source verification anchors. Sharp within-cohort verified-vs-claimed counterpoint: Happy Ring holds dual FDA 510(k) clearances (K240236 + K242224) for the same product category + similar capability claims.
- Was RingConn banned in the US?
No, RingConn was NOT banned in the US per Agent A Wave 2 biometric ingest correction. RingConn settled cleanly with Oura on the '178 patent and obtained a license. The entity that was blocked from the US market via the ITC final determination was Ultrahuman (subsequently restored via the Ring Pro unibody redesign cleared US Customs March 24 2026). Per DEPLOY's framework, the ITC-outcome correction matters editorially: trade-press coverage framing RingConn at the banned-from-US-market verification posture operates outside Agent A primary-source-anchored verification.
- What's the difference between RingConn and Oura?
Commercial model + IP-litigation outcome are the structural distinctions. RingConn: $279 subscription-free one-time purchase; settled-licensed with Oura on '178 patent. Oura: hardware purchase + $5.99/mo Oura Membership for AI insights; '178 patent holder + plaintiff in the ITC dispute. Per DEPLOY's biometric cluster framework, RingConn anchors the subscription-free ring archetype while Oura anchors the purchase+membership ring archetype. Both ship as in-cohort ring sub-cohort entries; both operate without FDA clearance on sleep apnea diagnosis (RingConn AHI claimed-not-cleared; Oura without sleep apnea claim at the AHI verification layer).
- What's the difference between RingConn Gen 2 and Gen 3?
Per Agent A Wave 2 biometric ingest + slug audit, the RingConn registry entity scope is "RingConn (Gen 2 / Gen 3)": both generation variants covered within a single entity record at the line-level slug per DEPLOY's slug-discipline pattern. The Gen 2 + Gen 3 variants share the subscription-free commercial model + AHI-claimed-not-cleared verification posture. Per DEPLOY's framework, the line-level entity scope is editorially appropriate: multi-variant ring families verified at the line level (RingConn Gen 2/Gen 3 + Ultrahuman Air/Pro) rather than per-variant atomization preserves cohort framework boundary.
RingConn verified at subscription-free ring archetype within biometric cluster's ring sub-cohort. $279 one-time purchase commercial model (distinct from Oura purchase+membership + Whoop subscription-only). CRITICAL CAP-FLAG: AHI 90.7%-claimed accuracy but NOT FDA-cleared per Agent A Wave 2 biometric ingest; company PR explicit 'actively pursuing clearance' + 'not intended to diagnose.' Within-cohort verified-vs-claimed counterpoint to Happy Ring's actual FDA 510(k) clearances (K240236 + K242224). ITC outcome correction per Agent A: RingConn settled-licensed with Oura on '178 patent; NOT banned from US market; Ultrahuman was the blocked entity. Line-level entity scope: RingConn (Gen 2 / Gen 3) covers both generation variants within single modelName. How DEPLOY verifies →
Continue reading
What is Happy Ring?
FDA-cleared + service-gated ring archetype; dual K240236 + K242224 clearances; sharp verified-vs-claimed counterpoint to RingConn AHI claims.
Read article →
What is Ultrahuman Ring?
Market-access-redesigned ring; US blocked Oct 21 2025 then restored Mar 24 2026 via Ring Pro unibody redesign.
Read article →
What is Whoop?
Subscription-only band cohort exemplar; ~$478 Year 1 effective cost; BP Insights FDA Warning Letter dispute unresolved.
Read article →
The biometric cluster
Biometric cohort framework; ring sub-cohort archetypes + verified-vs-claimed framework operating at form-factor-cell granularity.
Read article →
Compare alternatives
RingConn registry companyRingConn registry modelRingConn consumer price pageBiometric cluster